Literature DB >> 15500847

Amino acid sequence of a thrombin like enzyme, elegaxobin II, from the venom of Trimeresurus elegans (Sakishima-Habu).

Etsuko Oyama1, Hidenobu Takahashi.   

Abstract

The amino acid sequence of a thrombin like enzyme , named elegaxobin II, isolated from the venom of Trimeresurus elegans (Sakishima-habu) was determined by Edman sequencing of the peptides which was derived from digests with cyanogen bromide, achromobacter protease I, trypsin, endoproteinase Asp-N, and chymotrypsin. Elegaxobin II consisted of 233 amino acids and showed conservation of the catalytic amino acid residues (His(57), Asp(102), and Ser(195)) of chymotrypsin family serine protease in its amino acid sequence. The carboxyterminal amino acid, Leu, was determined using carboxypeptidase Y. This enzyme contains glucosamine and an N-linked glycosylation site. Elegaxobin II was 91% homologous in sequence to elegaxobin and protease I from the same snake venom, and it was 67, 75, 31 and 26% homologous in sequences to flavoxobin, KN-BJ 2, human kallikrein and bovine thrombin, respectively. Elegaxobin II lacked thrombin's ETW (146-148) loop, as well as its functionally important YPPW (60-insertion loop).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15500847     DOI: 10.1016/j.toxicon.2004.07.007

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  2 in total

1.  TMPRSS12 Is an Activating Protease for Subtype B Avian Metapneumovirus.

Authors:  Bingling Yun; Yao Zhang; Yongzhen Liu; Xiaolu Guan; Yongqiang Wang; Xiaole Qi; Hongyu Cui; Changjun Liu; Yanping Zhang; Honglei Gao; Li Gao; Kai Li; Yulong Gao; Xiaomei Wang
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

2.  Quantitative high-throughput profiling of snake venom gland transcriptomes and proteomes (Ovophis okinavensis and Protobothrops flavoviridis).

Authors:  Steven D Aird; Yutaka Watanabe; Alejandro Villar-Briones; Michael C Roy; Kouki Terada; Alexander S Mikheyev
Journal:  BMC Genomics       Date:  2013-11-14       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.